Reaction
Type Iia Hyperlipidaemia reporting signals
As of the last recalculation, Type Iia Hyperlipidaemia appears in 224 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is LOVASTATIN (PRR 269.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lovastatin | 56 | 269.9 | 270.5 |
| Ezetimibe | 65 | 113.1 | 113.2 |
| Inclisiran | 7 | 83.7 | 83.8 |
| Atorvastatin Calcium, Film Coated | 48 | 80.6 | 80.7 |
| Evolocumab | 69 | 56.7 | 56.7 |
| Alirocumab | 6 | 22.8 | 22.8 |